Postoperative morphine consumption in children with sickle-cell disease

Area of Science:

• Anesthesiology
• Pediatric Surgery
• Hematology

Background:

• Effective pain management is crucial in perioperative care for sickle-cell disease patients.
• Understanding analgesic needs is key to improving outcomes.

Purpose of the Study:

• To compare postoperative morphine consumption and pain scores in pediatric patients with and without sickle-cell disease undergoing laparoscopic cholecystectomy.

Main Methods:

• Retrospective review of medical records for pediatric patients receiving patient-controlled analgesia (PCA) post-laparoscopic cholecystectomy.
• Data collected included morphine consumption, pain scores (visual analogue scale), and perioperative outcomes.

Main Results:

• Sickle-cell disease patients consumed over double the morphine compared to non-sickle-cell patients (1.58 vs. 0.65 mg/kg).
• Sickle-cell patients reported higher pain scores initially and required longer PCA use (51 vs. 21 hours).
• Postoperative hospital stay was significantly longer for sickle-cell patients (3.4 vs. 1.5 days).

Conclusions:

• Pediatric patients with sickle-cell disease require substantially more analgesia and experience prolonged pain postoperatively.
• These findings suggest multifactorial origins, potentially involving pain perception, opioid response, and psychosocial factors.
• Results underscore the need for specialized pain management protocols for sickle-cell disease patients undergoing surgery.